Navigating the unseen peril: safeguarding medical imaging in the age of AI von Maertens, Alexandra, Brykman, Steve, Hartung, Thomas, Gafita, Andrei, Bai, Harrison, Hoelzer, David, Skoudis, Ed, Paller, Channing Judith

Volltext

The somatic mutation landscape of germline CHEK2- altered prostate cancer von Nizialek, Emily, Lotan, Tamara L., Isaacs, William B., Yegnasubramanian, Srinivasan, Paller, Channing Judith, Antonarakis, Emmanuel S.

Volltext

Germline BRCA2 , ATM and CHEK2 alterations shape somatic mutation landscapes in prostate cancer von Nakazawa, Mari, Fang, Mike, Lotan, Tamara L., Luo, Jun, Isaacs, William B., Paller, Channing Judith, Antonarakis, Emmanuel S.

Volltext

Clonal hematopoiesis of indeterminate potential (CHIP) and association with response to bipolar androgen therapy (BAT) von Holler, Albert E, Gondek, Lukasz, Tsai, Hua-Ling, Markowski, Mark Christopher, Paller, Channing Judith, Carducci, Michael Anthony, Denmeade, Samuel R., Antonarakis, Emmanuel S., Luo, Jun, Marshall, Catherine Handy

Volltext

Comparative effectiveness of systemic treatments for metastatic castration-sensitive prostate cancer: A parametric survival network meta-analysis of randomized controlled trials von Wang, Lin, Paller, Channing Judith, Hong, Hwanhee, De Felice, Anthony, Alexander, Caleb, Brawley, Otis W.

Volltext

A systematic review of immune checkpoint inhibitors (ICI) in non-clear cell renal cell cancer (nccRCC) subtypes von Reis, Ana Filipa, Odeny, Thomas A, Simão, Diana, Fontes-Sousa, Mario, Rodrigues, Ysel Chiara Vina, Paller, Channing Judith, Barata, Pedro C.

Volltext

Virtual genetics board for enhancing knowledge and practice of prostate cancer genetic testing: The ENGAGEMENT study von Giri, Veda N., Gross, Laura, Cheng, Heather H., Russo, Jessica, Paller, Channing Judith, Johnson, Jennifer M, Weg, Emily Steinberger, Loeb, Stacy

Volltext

Whole-food plant-based diet (WFPBD) to control weight and metabo-inflammation in overweight/obese men with prostate cancer (PC) receiving androgen deprivation therapy (ADT): A mult... von Jacobs, Nicole, Hootman, Katie, Fischer, Victoria, Pinnavaia, Nadja, Sfanos, Karen, Nauseef, Jones T., Molina, Ana M., Sternberg, Cora N., Tagawa, Scott T., Ballman, Karla V., Stein, Mark N., Paller, Channing Judith, Nanus, David M.

Volltext

Factors related to men’s experience with prostate cancer germline testing von Giri, Veda N., Gross, Laura, Hartman, Rebecca, Leader, Amy, Whang, Young E., Couvillon, Anna, Cheng, Heather H., Paller, Channing Judith, Loeb, Stacy, Karsh, Lawrence Ivan, Friedman, Sue J., Beer, Tomasz M., Sokolova, Alexandra, Keith, Scott W.

Volltext

A phase I dose escalation study of PCUR-101 in men with metastatic castration-resistant prostate cancer (mCRPC) von Kyriakopoulos, Christos, Paller, Channing Judith, Verma, Ajit, Kader, Karim, Kittrelle, Jeff, Borgström, Per G, Vaishampayan, Ulka N.

Volltext

Overcoming resistance to antiandrogens with a TGF-β RI inhibitor in preclinical mouse model of PCa von Paller, Channing Judith, Pu, Hong, Begemann, Diane, Nakazawa, Mary, Kyprianou, Natasha

Volltext

Randomized placebo-controlled trial of intravenous vitamin C plus docetaxel in metastatic prostate cancer von Paller, Channing Judith, Zahurak, Marianna, Heath, Elisabeth I., Kelly, William Kevin, Hoimes, Christopher J., Taksey, Jason David, Marshall, Catherine Handy, Markowski, Mark Christopher, Barata, Pedro C., Rudek, Michelle A., Nauroth, Julie, Wang, Lin, Durham, Jennifer N., Eisenberger, Mario A., Carducci, Michael Anthony, Denmeade, Samuel R., Levine, Mark

Volltext

Learned lessons from a US-wide outreach program to broaden enrollment to the PROMISE Registry, a prostate cancer genetic registry von Paller, Channing Judith, Lorentz, Justin, Appleman, Leonard Joseph, Armstrong, Andrew J., Barata, Pedro C., Dreicer, Robert, Elrod, Jo Ann, Fleming, Mark T., George, Christopher M., Heath, Elisabeth I., Hussain, Maha H. A., Mao, Shifeng S., McKay, Rana R., Morgans, Alicia K., Orton, Matthew, Pili, Roberto, Saraiya, Biren, Sokolova, Alexandra, Stadler, Walter Michael, Cheng, Heather H.

Volltext

Phase 2 study of olaparib (without ADT) in men with biochemically recurrent prostate cancer (BCR) after prostatectomy von Marshall, Catherine Handy, Teply, Benjamin A., Lim, Su Jin, Wang, Hao, Mao, Shifeng S., Kelly, William Kevin, Paller, Channing Judith, Markowski, Mark Christopher, Denmeade, Samuel R., Carducci, Michael Anthony, Eisenberger, Mario A., King, Serina, Sullivan, Rana, Lotan, Tamara L., Antonarakis, Emmanuel S.

Volltext

Prostate-specific antigen value at 3 & 7 months (PSA-3mo, PSA-7mo) and overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivati... von Parikh, Mamta, Tangen, Catherine, Hussain, Maha H. A., Gupta, Shilpa, Jo, Yeonjung, Harzstark, Andrea, Paller, Channing Judith, George, Saby, Zibelman, Matthew R., Cheng, Heather H., Maughan, Benjamin L., Zhang, Jingsong, Pachynski, Russell Kent, Bryce, Alan Haruo, Lin, Daniel W., Quinn, David I., Thompson, Ian M, Dorff, Tanya B., Lara, Primo N, Agarwal, Neeraj

Volltext

RESTORE: A single-arm, open-label phase II trial of bipolar androgen therapy (BAT) in men with metastatic castration resistant prostate cancer (mCRPC)—A comparison of post-abirater... von Markowski, Mark Christopher, Wang, Hao, Schweizer, Michael Thomas, Carducci, Michael Anthony, Paller, Channing Judith, Teply, Benjamin A., Eisenberger, Mario A., Luo, Jun, Antonarakis, Emmanuel S., Denmeade, Samuel R.

Volltext

PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness von Paller, Channing Judith, Lorentz, Justin, Appleman, Leonard Joseph, Armstrong, Andrew J., Barata, Pedro C., Dreicer, Robert, Elrod, Jo Ann, Fleming, Mark T., George, Christopher M., Heath, Elisabeth I., Hussain, Maha H. A., Mao, Shifeng S., McKay, Rana R., Morgans, Alicia K., Orton, Matthew, Pili, Roberto, Saraiya, Biren, Sokolova, Alexandra, Stadler, Walter Michael, Cheng, Heather H.

Volltext

Interim results of aasur: A single arm, multi-center phase 2 trial of apalutamide (A) + abiraterone acetate + prednisone (AA+P) + leuprolide with stereotactic ultra-hypofractionate... von McBride, Sean Matthew, Spratt, Daniel Eidelberg, Kollmeier, Marisa, Abida, Wassim, Xiao, Han, Slovin, Susan F., Paller, Channing Judith, Deville, Curtiland, Den, Robert Benjamin, Hearn, Jason W.D., Scher, Howard I., Zelefsky, Michael J., Rathkopf, Dana E.

Volltext

COMBAT-CRPC: Concurrent administration of bipolar androgen therapy (BAT) and nivolumab in men with metastatic castration-resistant prostate cancer (mCRPC) von Markowski, Mark Christopher, Taplin, Mary-Ellen, Aggarwal, Rahul Raj, Wang, Hao, Lalji, Aliya, Paller, Channing Judith, Marshall, Catherine Handy, Carducci, Michael Anthony, Eisenberger, Mario A., De Marzo, Angelo M, Denmeade, Samuel R., Antonarakis, Emmanuel S.

Volltext

Phase II, double-blind, randomized study of salvage radiation therapy (SRT) plus enzalutamide or placebo for high-risk PSA-recurrent prostate cancer after radical prostatectomy: Th... von Tran, Phuoc T., Lowe, Kathryn, Wang, Hao, Tsai, Hua-Ling, Song, Daniel Y., Hung, Arthur, Hearn, Jason W.D., Lotan, Tamara L., Paller, Channing Judith, Markowski, Mark Christopher, Denmeade, Samuel R., Carducci, Michael Anthony, Eisenberger, Mario A., Orton, Matthew, Deville, Curtiland, Liauw, Stanley L., Heath, Elisabeth I., Desai, Neil B, Beer, Tomasz M., Antonarakis, Emmanuel S.

Volltext